Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

Clinical trial NCT03520790 · TERMINATED

Trial details

NCT number: NCT03520790
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2018-12-05
Primary completion: 2024-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.